Evaluation of seasonal influenza vaccination effectiveness based on antibody efficacy among the institutionalized elderly in Japan

Vaccine. 2010 Aug 9;28(35):5664-8. doi: 10.1016/j.vaccine.2010.06.061.

Abstract

Influenza vaccination efficacy was evaluated in 114 institutionalized elderly people in 2002/03. Strain A/H3N2 was isolated; 44 and 8 subjects had sudden-onset fever (> or = 37.8 degrees C) and kit-diagnosed influenza, respectively. Odds ratios adjusted for age, sex, comorbidity, and vaccine strain (OR(adj)) were determined using multiple logistic regression. Seroprotected patients (haemagglutination-inhibition antibody titre > or = 1:40) had lower incidence of fever (OR(adj), 0.35; 95% confidence interval [CI], 0.09-1.28) and kit-diagnosed influenza (OR(adj), 0.35; 95% CI, 0.03-4.64) than patients without seroprotection (antibody efficacy, approximately 65%). Seroprotective levels of vaccination-induced antibodies probably prevent influenza among the institutionalized elderly, although statistical significance could not be confirmed owing to the sample size.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • Female
  • Hemagglutination Inhibition Tests
  • Humans
  • Influenza A Virus, H3N2 Subtype
  • Influenza Vaccines / immunology*
  • Influenza, Human / epidemiology*
  • Influenza, Human / prevention & control
  • Japan / epidemiology
  • Logistic Models
  • Male
  • Odds Ratio
  • Prospective Studies

Substances

  • Antibodies, Viral
  • Influenza Vaccines